Detection of Neisseria meningitidis in a patient receiving ravulizumab by the FilmArray® Meningitis/Encephalitis panel- A case report
Copyright © 2021. Published by Elsevier Ltd..
The FilmArray® Meningitis/Encephalitis Panel detects the 14 most frequent pathogens causing meningitis and/or encephalitis. The use of FilmArray® ME is an alternative when culture-based methods are limited because an early antibiotic treatment. We describe the case of a 43-year-old woman receiving ravulizumab, a complement component C5 inhibitor, in whom the FilmArray® ME technique successfully identified Neisseria meningitidis in cerebrospinal fluid.
| Errataetall: |
CommentIn: J Infect. 2022 Jun;84(6):834-872. - PMID 35346732 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
|---|---|
| Enthalten in: |
The Journal of infection - 82(2021), 6 vom: 06. Juni, Seite e22-e23 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Navarro-Carrera, Paula [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti C5 monoclonal antibody |
|---|
| Anmerkungen: |
Date Completed 02.07.2021 Date Revised 06.07.2022 published: Print-Electronic CommentIn: J Infect. 2022 Jun;84(6):834-872. - PMID 35346732 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2021.03.014 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323181783 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323181783 | ||
| 003 | DE-627 | ||
| 005 | 20231225183630.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2021.03.014 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1077.xml |
| 035 | |a (DE-627)NLM323181783 | ||
| 035 | |a (NLM)33762163 | ||
| 035 | |a (PII)S0163-4453(21)00131-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Navarro-Carrera, Paula |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Detection of Neisseria meningitidis in a patient receiving ravulizumab by the FilmArray® Meningitis/Encephalitis panel- A case report |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.07.2021 | ||
| 500 | |a Date Revised 06.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: J Infect. 2022 Jun;84(6):834-872. - PMID 35346732 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021. Published by Elsevier Ltd. | ||
| 520 | |a The FilmArray® Meningitis/Encephalitis Panel detects the 14 most frequent pathogens causing meningitis and/or encephalitis. The use of FilmArray® ME is an alternative when culture-based methods are limited because an early antibiotic treatment. We describe the case of a 43-year-old woman receiving ravulizumab, a complement component C5 inhibitor, in whom the FilmArray® ME technique successfully identified Neisseria meningitidis in cerebrospinal fluid | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Anti C5 monoclonal antibody | |
| 650 | 4 | |a Antimicrobial prophylaxis | |
| 650 | 4 | |a FilmArray Meningitis/Encephalitis | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a ravulizumab |2 NLM | |
| 650 | 7 | |a C3VX249T6L |2 NLM | |
| 700 | 1 | |a García-Rodríguez, Julio |e verfasserin |4 aut | |
| 700 | 1 | |a Cendejas-Bueno, Emilio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 82(2021), 6 vom: 06. Juni, Seite e22-e23 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:82 |g year:2021 |g number:6 |g day:06 |g month:06 |g pages:e22-e23 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2021.03.014 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 82 |j 2021 |e 6 |b 06 |c 06 |h e22-e23 | ||